Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shearer

Showing results (141-150 of 677) with videos related to

Pageof 68
Sort By:
Research in Immunology|September 1, 1995
Role of IL12 in HIV disease/AIDSC Chougnet, M Clerici, G M Shearer
Journal of the National Cancer Institute|April 3, 1996
The tumor enhancement phenomenon: reinterpretation from a Th1/Th2 perspectiveM Clerici, E Clerici, G M Shearer
Journal of Cellular Physiology|April 1, 1978
Growth requirements of calf lens epithelium in cultureJ Taylor-Papadimitriou, M Shearer, D Watling
Transplantation|September 1, 1984
Modulation of T cell differentiation, antigen expression, and radiosensitivity of suppressor cells during late phases of graft-versus-host reactivityU Hurtenbach, T Tsuchida, G M Shearer
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analoguesJ Taylor-Papadimitriou, M Shearer, D Griffin
Archives of Surgery (Chicago, Ill. : 1920)|October 29, 2010
Production of experimental portal hypertension in the dog; anatomy of the hepatic veins in the dogD KERSHNER, T C HOOTON, E M SHEARER
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
H-2 linked genetic control of priming for secondary cytotoxic responses to autologous cells modified with low concentrations of trinitrobenzene sulfonateR P Polisson, H Fujiwara, G M Shearer
Immunobiology|February 1, 1982
Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?H Fujiwara, R B Levy, G M Shearer
Immunology Today|March 31, 1999
Alloimmunization for immune-based therapy and vaccine design against HIV/AIDSG M Shearer, L A Pinto, M Clerici
Journal of Clinical Immunology|August 17, 2001
Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responsesV Blazevic, C M Trubey, G M Shearer
Pageof 68

Showing results (141-150 of 677) with videos related to

Sort By:
Pageof 68
Research in Immunology|September 1, 1995
Role of IL12 in HIV disease/AIDSC Chougnet, M Clerici, G M Shearer
Journal of the National Cancer Institute|April 3, 1996
The tumor enhancement phenomenon: reinterpretation from a Th1/Th2 perspectiveM Clerici, E Clerici, G M Shearer
Journal of Cellular Physiology|April 1, 1978
Growth requirements of calf lens epithelium in cultureJ Taylor-Papadimitriou, M Shearer, D Watling
Transplantation|September 1, 1984
Modulation of T cell differentiation, antigen expression, and radiosensitivity of suppressor cells during late phases of graft-versus-host reactivityU Hurtenbach, T Tsuchida, G M Shearer
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1987
Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analoguesJ Taylor-Papadimitriou, M Shearer, D Griffin
Archives of Surgery (Chicago, Ill. : 1920)|October 29, 2010
Production of experimental portal hypertension in the dog; anatomy of the hepatic veins in the dogD KERSHNER, T C HOOTON, E M SHEARER
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
H-2 linked genetic control of priming for secondary cytotoxic responses to autologous cells modified with low concentrations of trinitrobenzene sulfonateR P Polisson, H Fujiwara, G M Shearer
Immunobiology|February 1, 1982
Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?H Fujiwara, R B Levy, G M Shearer
Immunology Today|March 31, 1999
Alloimmunization for immune-based therapy and vaccine design against HIV/AIDSG M Shearer, L A Pinto, M Clerici
Journal of Clinical Immunology|August 17, 2001
Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responsesV Blazevic, C M Trubey, G M Shearer
Pageof 68